These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8251456)

  • 1. Symptomatic ascites complicating GnRH analogue use for myoma shrinkage.
    Harding SG; Pesce A; McMillan L
    Br J Obstet Gynaecol; 1993 Nov; 100(11):1054-6. PubMed ID: 8251456
    [No Abstract]   [Full Text] [Related]  

  • 2. GnRH agonists: an alternative to surgery?
    Maheux R
    Hum Reprod; 1996 Nov; 11 Suppl 3():43-50. PubMed ID: 9147101
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between gonadotropin-releasing hormone agonist and myoma cellular activity: preliminary findings on positron emission tomography.
    Lee WL; Liu RS; Yuan CC; Chao HT; Wang PH
    Fertil Steril; 2001 Mar; 75(3):638-9. PubMed ID: 11239559
    [No Abstract]   [Full Text] [Related]  

  • 4. Goserelin administration causing an acute abdomen in a patient with a fibroid uterus.
    Basu M; Ahmed AI
    J Obstet Gynaecol; 2007 Jan; 27(1):90-1. PubMed ID: 17365475
    [No Abstract]   [Full Text] [Related]  

  • 5. Removal of fibromyomas by laparoscopic surgery after preoperative GnRH analogue--an alternative to abdominal hysterectomy or myomectomy.
    Wood C; Maher P
    Aust N Z J Obstet Gynaecol; 1996 Nov; 36(4):464-8. PubMed ID: 9006835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
    Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The place of Zoladex in deferred surgery for uterine fibroids. Zoladex Myoma Study Group.
    Gerris J; Degueldre M; Peters AA; Romao F; Stjernquist M; al-Taher H
    Horm Res; 1996; 45(6):279-84. PubMed ID: 8793522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deferred versus immediate surgery for uterine fibroids: clinical trial results.
    Audebert AJ; Madenelat P; Querleu D; Pontonnier G; Racinet C; Renaud R; Gillet JY; Raudrant D; Lansac J; Brettes JP
    Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():29-32. PubMed ID: 8199102
    [No Abstract]   [Full Text] [Related]  

  • 10. Goserelin (Zoladex) and the anaemic patient.
    Vercellini P; Crosignani PG
    Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():33-7. PubMed ID: 8199103
    [No Abstract]   [Full Text] [Related]  

  • 11. Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
    McClelland HR; Quinn AJ
    Ulster Med J; 1992 Apr; 61(1):51-5. PubMed ID: 1535743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin.
    Crow J; Gardner RL; McSweeney G; Shaw RW
    Int J Gynecol Pathol; 1995 Jul; 14(3):235-42. PubMed ID: 8600075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myomectomy performed after Zoladex preparation with subsequent repair of the uterine wall via a balloon catheter in the uterine cavity].
    Nikolov A; Raĭcheva R; Maĭnkhard K
    Akush Ginekol (Sofiia); 1998; 37(1):55-7. PubMed ID: 9770805
    [No Abstract]   [Full Text] [Related]  

  • 14. Presurgical treatment of uterine fibroids by using gonadotropin-releasing hormone agonists.
    Falsetti L; Mazzani MD; Rubessa S; Ruggeri C
    Acta Eur Fertil; 1992; 23(1):29-32. PubMed ID: 1293897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of goserelin effectiveness based on assessment of inflammatory cytokines and symptoms in uterine leiomyoma.
    Mohammed NH; Al-Taie A; Albasry Z
    Int J Clin Pharm; 2020 Jun; 42(3):931-937. PubMed ID: 32350747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine myoma after cessation of gonadotropin-releasing hormone agonist: ultrasound and histopathologic findings.
    Wang PH; Yang AH; Yuan CC; Lee WL; Chao HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Nov; 61(11):625-9. PubMed ID: 9872018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas].
    Nikolov A; Karag'ozov I
    Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of goserelin (Zoladex) in the treatment of uterine myomas in infertile patients.
    Kopitović V; Bujas M; Fistes Topalski N; Pjević M; Ilić D; Kapamadzija A; Bujas I
    Med Pregl; 2001; 54(7-8):339-46. PubMed ID: 11905182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial.
    Mavrelos D; Ben-Nagi J; Davies A; Lee C; Salim R; Jurkovic D
    Hum Reprod; 2010 Sep; 25(9):2264-9. PubMed ID: 20663795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical uses of goserelin in gynecologic diseases and its safety].
    Tan SJ; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):58-60. PubMed ID: 10682460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.